Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Structure of an Agonist-Bound Human A2A Adenosine Receptor
Fei Xu,1
Huixian Wu,1
Vsevolod Katritch,2
Gye Won Han,1
Kenneth A. Jacobson,3
Zhan-Guo Gao,3
Vadim Cherezov,1
Raymond C. Stevens1,*
Abstract:
Activation of G protein–coupled receptors upon agonist binding is a critical step in the signaling cascade for this family of cell surface proteins. We report the crystal structure of the A2A adenosine receptor (A2AAR) bound to an agonist UK-432097 at 2.7 angstrom resolution. Relative to inactive, antagonist-bound A2AAR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes associated with the active-state opsin structure. Additionally, a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A2AAR and its ligand. The results define the molecule UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.
1 Department of Molecular Biology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. 2 Skaggs School of Pharmacy and Pharmaceutical Sciences and San Diego Supercomputer Center, University of California, San Diego, La Jolla, CA 92093, USA. 3 Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892, USA.
* To whom correspondence should be addressed. E-mail: stevens{at}scripps.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Valda Vinson (19 April 2011) Sci. Signal.4 (169), ec113.
[DOI: 10.1126/scisignal.4169ec113] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Structural Features for Functional Selectivity at Serotonin Receptors.
D. Wacker, C. Wang, V. Katritch, G. W. Han, X.-P. Huang, E. Vardy, J. D. McCorvy, Y. Jiang, M. Chu, F. Y. Siu, et al. (2013)
Science
340, 615-619
|Abstract »|Full Text »|PDF »
Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7.
A. Steen, S. Thiele, D. Guo, L. S. Hansen, T. M. Frimurer, and M. M. Rosenkilde (2013)
J. Biol. Chem.
288, 12511-12521
|Abstract »|Full Text »|PDF »
Functional fusions of T4 lysozyme in the third intracellular loop of a G protein-coupled receptor identified by a random screening approach in yeast.
E. Mathew, F.-X. Ding, F. Naider, and M. E. Dumont (2013)
Protein Eng. Des. Sel.
26, 59-71
|Abstract »|Full Text »|PDF »
Extracellular Loop II Modulates GTP Sensitivity of the Prostaglandin EP3 Receptor.
C. Natarajan, A. N. Hata, H. E. Hamm, R. Zent, and R. M. Breyer (2013)
Mol. Pharmacol.
83, 206-216
|Abstract »|Full Text »|PDF »
PheVI:09 (Phe6.44) as a Sliding Microswitch in Seven-transmembrane (7TM) G Protein-coupled Receptor Activation.
L. Valentin-Hansen, B. Holst, T. M. Frimurer, and T. W. Schwartz (2012)
J. Biol. Chem.
287, 43516-43526
|Abstract »|Full Text »|PDF »
Reengineering the Collision Coupling and Diffusion Mode of the A2A-adenosine Receptor: PALMITOYLATION IN HELIX 8 RELIEVES CONFINEMENT.
S. Keuerleber, P. Thurner, C. W. Gruber, J. Zezula, and M. Freissmuth (2012)
J. Biol. Chem.
287, 42104-42118
|Abstract »|Full Text »|PDF »
Sequential Conformational Rearrangements Dictate the Dynamics of Class C GPCR Activation.
The Thyrotropin Receptor Hinge Region as a Surrogate Ligand: Identification of Loci Contributing to the Coupling of Thyrotropin Binding and Receptor Activation.
C.-R. Chen, L. M. Salazar, S. M. McLachlan, and B. Rapoport (2012)
Endocrinology
153, 5058-5067
|Abstract »|Full Text »|PDF »
Helix 8 of leukotriene B4 receptor 1 inhibits ligand-induced internalization.
Y. Aratake, T. Okuno, T. Matsunobu, K. Saeki, R. Takayanagi, S. Furuya, and T. Yokomizo (2012)
FASEB J
26, 4068-4078
|Abstract »|Full Text »|PDF »
Modulation of Constitutive Activity and Signaling Bias of the Ghrelin Receptor by Conformational Constraint in the Second Extracellular Loop.
J. Mokrosinski, T. M. Frimurer, B. Sivertsen, T. W. Schwartz, and B. Holst (2012)
J. Biol. Chem.
287, 33488-33502
|Abstract »|Full Text »|PDF »
A Key Agonist-induced Conformational Change in the Cannabinoid Receptor CB1 Is Blocked by the Allosteric Ligand Org 27569.
The Arginine of the DRY Motif in Transmembrane Segment III Functions as a Balancing Micro-switch in the Activation of the {beta}2-Adrenergic Receptor.
L. Valentin-Hansen, M. Groenen, R. Nygaard, T. M. Frimurer, N. D. Holliday, and T. W. Schwartz (2012)
J. Biol. Chem.
287, 31973-31982
|Abstract »|Full Text »|PDF »
New Insights for Drug Design from the X-Ray Crystallographic Structures of G-Protein-Coupled Receptors.
Using ortholog sequence data to predict the functional relevance of mutations in G-protein-coupled receptors.
M. Coster, D. Wittkopf, A. Kreuchwig, G. Kleinau, D. Thor, G. Krause, and T. Schoneberg (2012)
FASEB J
26, 3273-3281
|Abstract »|Full Text »|PDF »
Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions.
W. Liu, E. Chun, A. A. Thompson, P. Chubukov, F. Xu, V. Katritch, G. W. Han, C. B. Roth, L. H. Heitman, A. P. IJzerman, et al. (2012)
Science
337, 232-236
|Abstract »|Full Text »|PDF »
Biased Signaling Pathways in {beta}2-Adrenergic Receptor Characterized by 19F-NMR.
J. J. Liu, R. Horst, V. Katritch, R. C. Stevens, and K. Wuthrich (2012)
Science
335, 1106-1110
|Abstract »|Full Text »|PDF »
A Novel Nonribose Agonist, LUF5834, Engages Residues That Are Distinct from Those of Adenosine-Like Ligands to Activate the Adenosine A2a Receptor.
J. R. Lane, C. Klein Herenbrink, G. J. P. van Westen, J. A. Spoorendonk, C. Hoffmann, and A. P. IJzerman (2012)
Mol. Pharmacol.
81, 475-487
|Abstract »|Full Text »|PDF »
Crystal Structure of a Lipid G Protein-Coupled Receptor.
M. A. Hanson, C. B. Roth, E. Jo, M. T. Griffith, F. L. Scott, G. Reinhart, H. Desale, B. Clemons, S. M. Cahalan, S. C. Schuerer, et al. (2012)
Science
335, 851-855
|Abstract »|Full Text »|PDF »
AMP Is an Adenosine A1 Receptor Agonist.
J. E. Rittiner, I. Korboukh, E. A. Hull-Ryde, J. Jin, W. P. Janzen, S. V. Frye, and M. J. Zylka (2012)
J. Biol. Chem.
287, 5301-5309
|Abstract »|Full Text »|PDF »
Structural aspects of M3 muscarinic acetylcholine receptor dimer formation and activation.
J. Hu, D. Thor, Y. Zhou, T. Liu, Y. Wang, S. M. McMillin, R. Mistry, R. A. J. Challiss, S. Costanzi, and J. Wess (2012)
FASEB J
26, 604-616
|Abstract »|Full Text »|PDF »
Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.
R. M. Potter, K. G. Harikumar, S. V. Wu, and L. J. Miller (2012)
J. Lipid Res.
53, 137-148
|Abstract »|Full Text »|PDF »
Pocketome: an encyclopedia of small-molecule binding sites in 4D.
I. Kufareva, A. V. Ilatovskiy, and R. Abagyan (2012)
Nucleic Acids Res.
40, D535-D540
|Abstract »|Full Text »|PDF »
The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery.
J. A. Salon, D. T. Lodowski, and K. Palczewski (2011)
Pharmacol. Rev.
63, 901-937
|Abstract »|Full Text »|PDF »
Developing Chemical Genetic Approaches to Explore G Protein-Coupled Receptor Function: Validation of the Use of a Receptor Activated Solely by Synthetic Ligand (RASSL).
E. Alvarez-Curto, R. Prihandoko, C. S. Tautermann, J. M. Zwier, J. D. Pediani, M. J. Lohse, C. Hoffmann, A. B. Tobin, and G. Milligan (2011)
Mol. Pharmacol.
80, 1033-1046
|Abstract »|Full Text »|PDF »
Activation mechanism of the {beta}2-adrenergic receptor.
R. O. Dror, D. H. Arlow, P. Maragakis, T. J. Mildorf, A. C. Pan, H. Xu, D. W. Borhani, and D. E. Shaw (2011)
PNAS
108, 18684-18689
|Abstract »|Full Text »|PDF »